Skip to main content
PMC home page
Philosophical Transactions of the Royal Society B: Biological Sciences logoLink to Philosophical Transactions of the Royal Society B: Biological Sciences
. 1999 Jun 29;354(1386):971–979. doi: 10.1098/rstb.1999.0448

From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease

S W Davies
PMCID: PMC1692612  PMID: 10434295

Abstract

Huntington's disease (HD) is an inherited progressive neurodegenerative disease caused by the expansion of a polyglutamine repeat sequence within a novel protein. Recent work has shown that abnormal intranuclear inclusions of aggregated mutant protein within neurons is a characteristic feature shared by HD and several other diseases involving glutamine repeat expansion. This suggests that in each of the these disorders the affected nerve cells degenerate as a result of these abnormal inclusions. A transgenic mouse model of HD has been generated by introducing exon 1 of the HD gene containing a highly expanded CAG sequence into the mouse germline. These mice develop widespread neuronal intranuclear inclusions and neurodegeneration specifically within those areas of the brain known to degenerate in HD. We have investigated the sequence of pathological changes that occur after the formation of nuclear inclusions and that precede neuronal cell death in these cells. Although the relation between inclusion formation and neurodegeneration has recently been questioned, a full characterization of the pathways linking protein aggregation and cell death will resolve some of these controversies and will additionally provide new targets for potential therapies.

Full Text

The Full Text of this article is available as a PDF (747.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bates G. P., Mangiarini L., Davies S. W. Transgenic mice in the study of polyglutamine repeat expansion diseases. Brain Pathol. 1998 Oct;8(4):699–714. doi: 10.1111/j.1750-3639.1998.tb00196.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Becher M. W., Kotzuk J. A., Sharp A. H., Davies S. W., Bates G. P., Price D. L., Ross C. A. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis. 1998 Apr;4(6):387–397. doi: 10.1006/nbdi.1998.0168. [DOI] [PubMed] [Google Scholar]
  3. Bhide P. G., Day M., Sapp E., Schwarz C., Sheth A., Kim J., Young A. B., Penney J., Golden J., Aronin N. Expression of normal and mutant huntingtin in the developing brain. J Neurosci. 1996 Sep 1;16(17):5523–5535. doi: 10.1523/JNEUROSCI.16-17-05523.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clarke P. G. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 1990;181(3):195–213. doi: 10.1007/BF00174615. [DOI] [PubMed] [Google Scholar]
  5. Cummings C. J., Mancini M. A., Antalffy B., DeFranco D. B., Orr H. T., Zoghbi H. Y. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet. 1998 Jun;19(2):148–154. doi: 10.1038/502. [DOI] [PubMed] [Google Scholar]
  6. Davies S. W., Beardsall K., Turmaine M., DiFiglia M., Aronin N., Bates G. P. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet. 1998 Jan 10;351(9096):131–133. doi: 10.1016/S0140-6736(97)08360-8. [DOI] [PubMed] [Google Scholar]
  7. Davies S. W., Turmaine M., Cozens B. A., DiFiglia M., Sharp A. H., Ross C. A., Scherzinger E., Wanker E. E., Mangiarini L., Bates G. P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997 Aug 8;90(3):537–548. doi: 10.1016/s0092-8674(00)80513-9. [DOI] [PubMed] [Google Scholar]
  8. De Rooij K. E., Dorsman J. C., Smoor M. A., Den Dunnen J. T., Van Ommen G. J. Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation. Hum Mol Genet. 1996 Aug;5(8):1093–1099. doi: 10.1093/hmg/5.8.1093. [DOI] [PubMed] [Google Scholar]
  9. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997 Sep 26;277(5334):1990–1993. doi: 10.1126/science.277.5334.1990. [DOI] [PubMed] [Google Scholar]
  10. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J. P., Carraway R., Reeves S. A. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron. 1995 May;14(5):1075–1081. doi: 10.1016/0896-6273(95)90346-1. [DOI] [PubMed] [Google Scholar]
  11. Dragunow M., Faull R. L., Lawlor P., Beilharz E. J., Singleton K., Walker E. B., Mee E. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport. 1995 May 9;6(7):1053–1057. doi: 10.1097/00001756-199505090-00026. [DOI] [PubMed] [Google Scholar]
  12. Earnshaw W. C. Nuclear changes in apoptosis. Curr Opin Cell Biol. 1995 Jun;7(3):337–343. doi: 10.1016/0955-0674(95)80088-3. [DOI] [PubMed] [Google Scholar]
  13. Goedert M., Spillantini M. G., Davies S. W. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol. 1998 Oct;8(5):619–632. doi: 10.1016/s0959-4388(98)80090-1. [DOI] [PubMed] [Google Scholar]
  14. Gourfinkel-An I., Cancel G., Duyckaerts C., Faucheux B., Hauw J. J., Trottier Y., Brice A., Agid Y., Hirsch E. C. Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset. Neuroreport. 1998 Jun 1;9(8):1823–1826. doi: 10.1097/00001756-199806010-00028. [DOI] [PubMed] [Google Scholar]
  15. Gutekunst C. A., Levey A. I., Heilman C. J., Whaley W. L., Yi H., Nash N. R., Rees H. D., Madden J. J., Hersch S. M. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8710–8714. doi: 10.1073/pnas.92.19.8710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hayashi Y., Kakita A., Yamada M., Koide R., Igarashi S., Takano H., Ikeuchi T., Wakabayashi K., Egawa S., Tsuji S. Hereditary dentatorubral-pallidoluysian atrophy: detection of widespread ubiquitinated neuronal and glial intranuclear inclusions in the brain. Acta Neuropathol. 1998 Dec;96(6):547–552. doi: 10.1007/s004010050933. [DOI] [PubMed] [Google Scholar]
  17. Holmberg M., Duyckaerts C., Dürr A., Cancel G., Gourfinkel-An I., Damier P., Faucheux B., Trottier Y., Hirsch E. C., Agid Y. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet. 1998 May;7(5):913–918. doi: 10.1093/hmg/7.5.913. [DOI] [PubMed] [Google Scholar]
  18. Igarashi S., Koide R., Shimohata T., Yamada M., Hayashi Y., Takano H., Date H., Oyake M., Sato T., Sato A. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet. 1998 Feb;18(2):111–117. doi: 10.1038/ng0298-111. [DOI] [PubMed] [Google Scholar]
  19. Ii K., Ito H., Tanaka K., Hirano A. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J Neuropathol Exp Neurol. 1997 Feb;56(2):125–131. doi: 10.1097/00005072-199702000-00002. [DOI] [PubMed] [Google Scholar]
  20. Jackson G. R., Salecker I., Dong X., Yao X., Arnheim N., Faber P. W., MacDonald M. E., Zipursky S. L. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron. 1998 Sep;21(3):633–642. doi: 10.1016/s0896-6273(00)80573-5. [DOI] [PubMed] [Google Scholar]
  21. Jackson M., Gentleman S., Lennox G., Ward L., Gray T., Randall K., Morrell K., Lowe J. The cortical neuritic pathology of Huntington's disease. Neuropathol Appl Neurobiol. 1995 Feb;21(1):18–26. doi: 10.1111/j.1365-2990.1995.tb01024.x. [DOI] [PubMed] [Google Scholar]
  22. Kerr J. F., Wyllie A. H., Currie A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972 Aug;26(4):239–257. doi: 10.1038/bjc.1972.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. La Spada A. R., Clark A. W. Inherited neurodegenerative disorders caused by CAG/polyglutamine tract expansions: symposium introduction. Brain Pathol. 1997 Jul;7(3):877–880. doi: 10.1111/j.1750-3639.1997.tb00891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Li M., Miwa S., Kobayashi Y., Merry D. E., Yamamoto M., Tanaka F., Doyu M., Hashizume Y., Fischbeck K. H., Sobue G. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol. 1998 Aug;44(2):249–254. doi: 10.1002/ana.410440216. [DOI] [PubMed] [Google Scholar]
  25. Li M., Nakagomi Y., Kobayashi Y., Merry D. E., Tanaka F., Doyu M., Mitsuma T., Hashizume Y., Fischbeck K. H., Sobue G. Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy. Am J Pathol. 1998 Sep;153(3):695–701. doi: 10.1016/S0002-9440(10)65612-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lieberman A. P., Robitaille Y., Trojanowski J. Q., Dickson D. W., Fischbeck K. H. Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease. Lancet. 1998 Mar 21;351(9106):884–884. doi: 10.1016/S0140-6736(05)70296-8. [DOI] [PubMed] [Google Scholar]
  27. Lucassen P. J., Chung W. C., Kamphorst W., Swaab D. F. DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol. 1997 Aug;56(8):887–900. doi: 10.1097/00005072-199708000-00007. [DOI] [PubMed] [Google Scholar]
  28. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S. W. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996 Nov 1;87(3):493–506. doi: 10.1016/s0092-8674(00)81369-0. [DOI] [PubMed] [Google Scholar]
  29. Mengual E., Arizti P., Rodrigo J., Giménez-Amaya J. M., Castaño J. G. Immunohistochemical distribution and electron microscopic subcellular localization of the proteasome in the rat CNS. J Neurosci. 1996 Oct 15;16(20):6331–6341. doi: 10.1523/JNEUROSCI.16-20-06331.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ordway J. M., Tallaksen-Greene S., Gutekunst C. A., Bernstein E. M., Cearley J. A., Wiener H. W., Dure L. S., 4th, Lindsey R., Hersch S. M., Jope R. S. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell. 1997 Dec 12;91(6):753–763. doi: 10.1016/s0092-8674(00)80464-x. [DOI] [PubMed] [Google Scholar]
  31. Papp M. I., Lantos P. L. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain. 1994 Apr;117(Pt 2):235–243. doi: 10.1093/brain/117.2.235. [DOI] [PubMed] [Google Scholar]
  32. Paulson H. L., Das S. S., Crino P. B., Perez M. K., Patel S. C., Gotsdiner D., Fischbeck K. H., Pittman R. N. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann Neurol. 1997 Apr;41(4):453–462. doi: 10.1002/ana.410410408. [DOI] [PubMed] [Google Scholar]
  33. Paulson H. L., Perez M. K., Trottier Y., Trojanowski J. Q., Subramony S. H., Das S. S., Vig P., Mandel J. L., Fischbeck K. H., Pittman R. N. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997 Aug;19(2):333–344. doi: 10.1016/s0896-6273(00)80943-5. [DOI] [PubMed] [Google Scholar]
  34. Perutz M. F., Johnson T., Suzuki M., Finch J. T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5355–5358. doi: 10.1073/pnas.91.12.5355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Portera-Cailliau C., Hedreen J. C., Price D. L., Koliatsos V. E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci. 1995 May;15(5 Pt 2):3775–3787. doi: 10.1523/JNEUROSCI.15-05-03775.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ross C. A., Becher M. W., Colomer V., Engelender S., Wood J. D., Sharp A. H. Huntington's disease and dentatorubral-pallidoluysian atrophy: proteins, pathogenesis and pathology. Brain Pathol. 1997 Jul;7(3):1003–1016. doi: 10.1111/j.1750-3639.1997.tb00898.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bates G. P., Davies S. W., Lehrach H., Wanker E. E. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell. 1997 Aug 8;90(3):549–558. doi: 10.1016/s0092-8674(00)80514-0. [DOI] [PubMed] [Google Scholar]
  38. Schmidt T., Landwehrmeyer G. B., Schmitt I., Trottier Y., Auburger G., Laccone F., Klockgether T., Völpel M., Epplen J. T., Schöls L. An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients. Brain Pathol. 1998 Oct;8(4):669–679. doi: 10.1111/j.1750-3639.1998.tb00193.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Skinner P. J., Koshy B. T., Cummings C. J., Klement I. A., Helin K., Servadio A., Zoghbi H. Y., Orr H. T. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature. 1997 Oct 30;389(6654):971–974. doi: 10.1038/40153. [DOI] [PubMed] [Google Scholar]
  40. Sotrel A., Paskevich P. A., Kiely D. K., Bird E. D., Williams R. S., Myers R. H. Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology. 1991 Jul;41(7):1117–1123. doi: 10.1212/wnl.41.7.1117. [DOI] [PubMed] [Google Scholar]
  41. Spillantini M. G., Crowther R. A., Jakes R., Cairns N. J., Lantos P. L., Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett. 1998 Jul 31;251(3):205–208. doi: 10.1016/s0304-3940(98)00504-7. [DOI] [PubMed] [Google Scholar]
  42. Thomas L. B., Gates D. J., Richfield E. K., O'Brien T. F., Schweitzer J. B., Steindler D. A. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol. 1995 Jun;133(2):265–272. doi: 10.1006/exnr.1995.1029. [DOI] [PubMed] [Google Scholar]
  43. Trottier Y., Devys D., Imbert G., Saudou F., An I., Lutz Y., Weber C., Agid Y., Hirsch E. C., Mandel J. L. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet. 1995 May;10(1):104–110. doi: 10.1038/ng0595-104. [DOI] [PubMed] [Google Scholar]
  44. Vonsattel J. P., DiFiglia M. Huntington disease. J Neuropathol Exp Neurol. 1998 May;57(5):369–384. doi: 10.1097/00005072-199805000-00001. [DOI] [PubMed] [Google Scholar]
  45. Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D., Richardson E. P., Jr Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol. 1985 Nov;44(6):559–577. doi: 10.1097/00005072-198511000-00003. [DOI] [PubMed] [Google Scholar]
  46. Warrick J. M., Paulson H. L., Gray-Board G. L., Bui Q. T., Fischbeck K. H., Pittman R. N., Bonini N. M. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell. 1998 Jun 12;93(6):939–949. doi: 10.1016/s0092-8674(00)81200-3. [DOI] [PubMed] [Google Scholar]
  47. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]
  48. de la Monte S. M., Vonsattel J. P., Richardson E. P., Jr Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol. 1988 Sep;47(5):516–525. doi: 10.1097/00005072-198809000-00003. [DOI] [PubMed] [Google Scholar]

Articles from Philosophical Transactions of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES